(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACT AMYLYX CARE TEAM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ACT AMYLYX CARE TEAM

ST13

US500000097978760

Class

44, 45

Filing

97978760

Registration

7573822

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

02/25/2026

Trademark type

Combined

Nice classes

44, 45

Filing date

08/15/2022

Registration date

11/19/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/19/2024

Last transaction

02/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-09-00

First use in commerce

2022-09-00

Drawing code

3

Owner type

03

Owner location

Cambridge, MA, US

Examiner

LEVINE, HOWARD B

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of five dots varying in size at the top of the mark. Below the dots is the wording "ACT" in capital letters. To the right of the wording "ACT" is the wording "Amylyx" and below this wording "Amylyx" are the words "CARE" and "TEAM".

Holders and representatives

Holders

Amylyx Pharmaceuticals, Inc.

Representatives

Cynthia Johnson Walden Fish & Richardson P.C.

Technical classification

Nice Classes

Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Consulting services in the field of medical patient care and medical services

Class 45

Providing patient advocate and case management servicescoordinating the procurementadministrationdelivery of medication for patients undergoing medical treatment; Providing patient advocate and case management servicespatient personal advocacy services to meet the needs of patients undergoing medical treatment

Publications

History of USPTO decisions and trademark events.

42 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/23/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/23/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/23/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/23/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/23/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/19/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/19/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

10/10/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/04/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/04/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/06/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

09/06/2024

IUAF

USE AMENDMENT FILED

04/04/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/04/2024

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

04/03/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/03/2024

DRRR

DIVISIONAL REQUEST RECEIVED

03/12/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

03/12/2024

EISU

TEAS STATEMENT OF USE RECEIVED

03/12/2024

EEXT

SOU TEAS EXTENSION RECEIVED

03/12/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/18/2023

PUBO

PUBLISHED FOR OPPOSITION

07/18/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/28/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/15/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

06/15/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/15/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

06/15/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/15/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/20/2023

GNFR

FINAL REFUSAL E-MAILED

04/20/2023

CNFR

FINAL REFUSAL WRITTEN

04/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/24/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/23/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/23/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/23/2022

GNRT

NON-FINAL ACTION E-MAILED

09/23/2022

CNRT

NON-FINAL ACTION WRITTEN

09/23/2022

DOCK

ASSIGNED TO EXAMINER

09/23/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/01/2022

NWAP

NEW APPLICATION ENTERED

08/18/2022

Continuous trademark protection

Get notified about every new filing that threatens ACT AMYLYX CARE TEAM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.